7056 Can ChatGPT Educate Multicultural Patients About Metabolic Syndrome?
Abstract Disclosure: G. Wu: None. E. Cheng: None. V.V. Toram: None. K. Rosen: None. A. Wong: None. W. Zhao: None. M. Del Buono: None. Background: Metabolic Syndrome, which affects Asians, is a major risk factor for diabetes. According to the National Institute of Health (NIH), 1 in 3 Americans have Metabolic Syndrome. Diabetes affects 30 million Americans, and 8 million more are undiagnosed. ChatGPT and Bard are Artificial Intelligence (AI) mediated LLMs launched on 11/30/2022 and 3/21/2023, respectively, that generate real-time conversational responses. Purpose: Can ChatGPT educate our multicultural patients about metabolic syndrome? Methods: 1. User prompt into ChatGPT and Bard: What is metabolic syndrome? I am a South Asian male, 40 years old, with a cholesterol level of 250 and a fasting blood sugar level of 120. The exact prompt was used with an Asian male as a substitute. 2. The prompt was translated into Telugu, Hindi, Simplified Chinese, and Traditional Chinese via Google Translate. 3. Flesch-Kincade (FK) method of ascertaining reading level was used. FK is used by the US Department of Education. Results: Flesch-Kincaid reading ease: ChatGPT: English=29.2, Telugu=60.1, Hindi=33.4, Chinese (Trad.)=14.5, Chinese (Simp.)=22.6 Bard: English=35.3, Telugu=52, Hindi=51.7, Chinese (Trad.)=52, Chinese (Simp.)=36.8 Language Group Comparison to English: ChatGPT: Indian Languages p=0.004; Chinese Languages p=0.081. Bard: Indian Languages p=0.007; Chinese Languages p=0.136. Of note, the Telegu response has one incorrect response. Conclusions: In conclusion, ChatGPT and Bard can provide factual responses based on English prompts. Foreign prompts can yield inaccurate information. Physicians and their teams still need to supervise patient usage. Presentation: 6/2/2024
Authors
- Gloria Wu (ORCID: https://orcid.org/0000-0002-0050-2401)
- Adrial Wong (ORCID: https://orcid.org/0009-0005-6566-5315)
- Viki V Toram
- Emily Cheng
- Kyler Rosen
- Milan Del Buono
- Weichen Zhao (ORCID: https://orcid.org/0000-0002-2711-6439)
Institutions
- University of California, San Francisco (US)
- Case Western Reserve University (US)
- University of California, Davis (US)
- University of California, Berkeley (US)
Publication Details
- Journal
- Journal of the Endocrine Society
- Published
- 2024-10-01
- DOI
- https://doi.org/10.1210/jendso/bvae163.1036
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00